LDL-Cholesterol
Showing 26 - 50 of 8,036
Type 2 Diabetes, Inflammation, Insulin Sensitivity/Resistance Trial in Montréal (Omega-3 fatty acids)
Recruiting
- Type 2 Diabetes
- +3 more
- Omega-3 fatty acids
-
Montréal, Quebec, CanadaMontreal Clinical Research Institute
Aug 27, 2021
Hyperlipemia Trial in Beijing (RBD7022, Placebo)
Recruiting
- Hyperlipemia
- RBD7022
- Placebo
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jun 12, 2023
Cardiovascular Diseases Trial in Reus (Aged black garlic extract, Placebo)
Completed
- Cardiovascular Diseases
- Aged black garlic extract
- Placebo
-
Reus, Tarragona, SpainCentro Tecnológico de Nutrición y Salud (Eurecat-Reus)
Feb 25, 2022
Coronary Artery Diseasse Trial in Seoul (fixed high potent statin therapy, targeted LDL-C goal statin)
Active, not recruiting
- Coronary Artery Diseasse
- fixed high potent statin therapy
- targeted LDL-C goal statin
-
Seoul, Korea, Republic ofDivision of Cardiology, Department of Internal Medicine, Yonsei
Jul 19, 2022
Hyper-LDL-cholesterolemia, Metabolic Syndrome Trial in Las Vegas, Oklahoma City, Stillwater (strawberries, Control powder)
Completed
- Hyper-LDL-cholesterolemia
- Metabolic Syndrome
- strawberries
- Control powder
-
Las Vegas, Nevada
- +2 more
Mar 12, 2021
Hyperlipidemia Trial in Leuven (Cholesfytol NG®) supplement)
Completed
- Hyperlipidemia
- Cholesfytol NG®) supplement
-
Leuven, BelgiumCliniques universitaires St-Luc and Institut de Recherche Expéri
Aug 18, 2023
Familial Hypercholesterolemia Trial in Odense C (Biochemistry interpretive comment on elevated LDL-C levels)
Not yet recruiting
- Familial Hypercholesterolemia
- Biochemistry interpretive comment on elevated LDL-C levels
-
Odense C, DenmarkDepartement of Cardiology, Odense University Hospital
Nov 10, 2022
Diabetes, Type 2, Diet, Vegetarian, Diet, Vegan Trial in Utrecht (12-week plant-based dietary program, Usual Diet)
Recruiting
- Diabetes Mellitus, Type 2
- +7 more
- 12-week plant-based dietary program
- Usual Diet
-
Utrecht, NetherlandsDepartment of Vascular Medicine UMC Utrecht
Mar 8, 2023
Hypercholesterolemia Trial (ezetimibe (+) simvastatin, Comparator: atorvastatin, Comparator: rosuvastatin)
Completed
- Hypercholesterolemia
- ezetimibe (+) simvastatin
- +2 more
- (no location specified)
Feb 7, 2022
Hypercholesterolemia Trial (ezetimibe (+) simvastatin, Comparator : rosuvastatin calcium, Comparator: Placebo (unspecified))
Completed
- Hypercholesterolemia
- ezetimibe (+) simvastatin
- +2 more
- (no location specified)
Feb 7, 2022
Hyperlipidemia Trial in Changsha, Chengdu, Beijing (100 mg inclisiran sodium (equivalent to 94.5 mg inclisiran), Placebo, 300 mg
Completed
- Hyperlipidemia
- 100 mg inclisiran sodium (equivalent to 94.5 mg inclisiran)
- +2 more
-
Changsha, Hunan, China
- +2 more
Dec 2, 2021
Hypercholesterolemia Trial (AB-LIFE with Monacolin K, Placebo)
Completed
- Hypercholesterolemia
- AB-LIFE with Monacolin K
- Placebo
- (no location specified)
Jan 19, 2021
Hypercholesterolemia Trial in Berlin (Calcium-Propionate 500mg, Placebo)
Completed
- Hypercholesterolemia
- Calcium-Propionate 500mg
- Placebo
-
Berlin, GermanyCharité Universitätsmedizin Berlin
Sep 14, 2020
Bariatric Surgery Trial in Barcelona (Gastric bypass, Sleeve gastrectomy)
Unknown status
- Bariatric Surgery
- Gastric bypass
- Sleeve gastrectomy
-
Barcelona, SpainHospital del Mar
Sep 22, 2020
Type 2 Diabetes Trial (HBA1C, Lipid profile, including total, LDL, and HDL cholesterol and Triglycerides, Urine analysis and
Not yet recruiting
- Type 2 Diabetes
- HBA1C
- +8 more
- (no location specified)
May 16, 2023
Atherosclerotic Cardiovascular Disease Trial in United States (Inclisiran)
Recruiting
- Atherosclerotic Cardiovascular Disease
-
Little Rock, Arkansas
- +43 more
Jan 20, 2023
Dyslipidemias Trial in Kayseri (Low-fat and low-cholesterol diet)
Completed
- Dyslipidemias
- Low-fat and low-cholesterol diet
-
Kayseri, Melikgazi, TurkeyErciyes University
May 15, 2021
Coronary Disease Trial (MK0653, ezetimibe / Duration of Treatment: 27 Weeks, MK0733, simvastatin / Duration of Treatment: 27
Completed
- Coronary Disease
- MK0653, ezetimibe / Duration of Treatment: 27 Weeks
- +2 more
- (no location specified)
Feb 7, 2022
Coronary Artery Disease, Atherosclerosis of Coronary Artery Trial in Nijmegen (Evolocumab 140 MG/ML [Repatha])
Recruiting
- Coronary Artery Disease
- Atherosclerosis of Coronary Artery
- Evolocumab 140 MG/ML [Repatha]
-
Nijmegen, Gelderland, NetherlandsRadboud University Medical Center
Jan 11, 2022
Atherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease Risk Equivelents, Elevated Low Density
Active, not recruiting
- Atherosclerotic Cardiovascular Disease
- +2 more
- Inclisiran
- Behavioural Support
-
Sale, Cheshire, United Kingdom
- +16 more
Jan 20, 2023
Familial Hypercholesterolaemia Trial in Czechia (Total cholesterol (TC) level test and direct Low density lipoprotein
Recruiting
- Familial Hypercholesterolaemia
- Total cholesterol (TC) level test and direct Low density lipoprotein cholesterol (LDL-C) level test
- DNA testing
-
Brno, Czechia
- +10 more
Nov 25, 2022
Improving Systolic BP and LDL-C Compared to Conventional
Not yet recruiting
- Hyperlipidemias
- Hypertension
- Rosuvastatin, Olmesartan Medoxomil
- (no location specified)
Jun 6, 2022
Cardiovascular Risk Factor, Pre Diabetes, High Blood Pressure Trial in Dubai (Exercise Time, Supervised Group Exercise)
Recruiting
- Cardiovascular Risk Factor
- +3 more
- Exercise Time
- Supervised Group Exercise
-
Dubai, Dubai Internet City, United Arab EmiratesEmirates Integrated Telecommunication Company (Du), Headquarters
Jul 6, 2021
Gut Microbiome, Cholesterol, LDL, Cholesterol, HDL Trial in Phoenix (Refined cornmeal flour, 50/50 refined cornmeal-bran mix,
Recruiting
- Gut Microbiome
- +2 more
- Refined cornmeal flour
- +2 more
-
Phoenix, ArizonaArizona Biomedical Collaborative
Jul 19, 2021